LEGN - Multiplikator forward rega marang pendapatan Legend Biotech Corp.

legendbiotech.com (LEGN) - logo korporat

Geographic reach across the US, Europe, and China creates a robust foundation for the expansion of Legend Biotech (LEGN). The forward P/S ratio confirms this trend, where 2.60 reflects the baseline level of the metric. Growth is supported by alliances with global pharma behemoths and the high cost of innovative treatments, which are consistently reimbursed by insurance companies.

legendbiotech.com - Prakiraan rega marang pendapatan LEGN (periode 04.07.2022 - 13.11.2026)

Legend Biotech Corp. - rincian analitis lan metrik utama (LEGN)

- rega pasar lan target rega analis:
Bagan rega Legend Biotech Corporation|LEGN - Bagan rega target
- statistik kapitalisasi pasar:
Biji pasar Legend Biotech Corp.|LEGN - Nilai Dipunlarasaken Utang lan Kas
- rincian valuasi buku bisnis:
Nilai Buku saben Saham Legend Biotech|LEGN - Nilai Buku Bisnis|Rasio Kapitalisasi Pasar marang Nilai Buku legendbiotech.com|LEGN - Aset Perusahaan
- informasi babagan utang lan solvabilitas:
Utang marang Ekuitas Legend Biotech|LEGN - Rasio utang jangka dawa marang modal|Utang jangka cendhak marang modal Legend Biotech|LEGN - Utang kumulatif perusahaan|Utang marang nilai buku Legend Biotech Corp.|LEGN - Silihan lan utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Legend Biotech|Rasio cepet legendbiotech.com
- rincian asil keuangan lan kelipatan valuasi:
LEGN - Bathi pungkasan|Proyeksi bathi mangsa ngarep Legend Biotech|LEGN - Kapitalisasi marang bathi|Rega marang bathi mangsa ngarep Legend Biotech Inc.|LEGN - Koefisien bali modal nimbang wutah|Pangali EV/EBITDA Legend Biotech Corp.|LEGN - Bathi operasional EBITDA|Bathi saben saham sajrone rolas wulan pungkasan Legend Biotech|LEGN - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan legendbiotech.com|LEGN - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Legend Biotech
- data pendapatan lan penerimaan dodolan:
LEGN - Pendapatan perusahaan|Prakiraan volume dodolan Legend Biotech Corporation|LEGN - Rega marang dodolan|Multiplikator Forward P/S Legend Biotech Corp.
Analisis wiwitan perusahaan:Legend Biotech Corporation (LEGN)
Produk asli Legend Biotech Corp.

The forward P/S reflects the ratio of current market value to expected revenue, allowing for an assessment of the investor's premium paid for potential revenue growth amid uncertainty. By analyzing the forward price-to-sales ratio, one can evaluate the capitalization stability of Legend Biotech (LEGN), based on the commercial success of Carvykti CAR-T therapy and the strategic alliance with J&J, which ensures the scaling of sales.

Pesaing wigati

Rasio rega marang prakiraan pendapatan Sana Biotechnology, Inc. SANA|Autolus Therapeutics PLC - Rasio rega marang prakiraan pendapatan|ALLO: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan RNAC (Selecta Biosciences Inc.)|CLLS: Multiplikator Forward P/S|Prakiraan rega marang pendapatan cariboubio.com CRBU|TIL (Instil Bio) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Genenta GNTA|Rasio rega marang prakiraan pendapatan Century Therapeutics (IPSC)|jaspertherapeutics.com - Kapitalisasi marang prakiraan pendapatan|Multiplikator Forward P/S SNTI (Senti Biosciences)|Adaptimmune Therapeutics plc (ADAP) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|CERO: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan TCRT (Alaunos Therapeutics)|ACHL (achillestx.com) - Multiplikator forward rega marang pendapatan|CRGX: Rasio rega marang pendapatan sing dikarepake|PSTX (Poseida Therapeutics) - Multiplikator Forward P/S|TSVT: Rega forward marang dodolan|Multiplikator Forward P/S GRCL